

PHAIN helps me quickly compare regimen pathways aligned to NCCN and ongoing trials—all in one visual map I can discuss with the MDT.


The pathway view makes it easy to see options when comorbidities change the route—and to explain the reasoning to patients.


We can verify dosing and contraindications straight from FDA labels, and see trial-eligible options as part of the same path.


I can see treatment steps and questions to ask my care team, so I'm prepared and confident about my choices.
Continuously explores clinical knowledge to surface guideline-concordant options, trials, and label constraints tailored to each diagnosis.
Navigate pathway-level visualizations, compare branches, and export steps for implementation or review.
Synthesizes national and international guidelines, FDA labels, and global clinical trial registries into one navigable view.
Example: Stage II breast cancer
Diagnosis and staging nodes
Neoadjuvant vs adjuvant branches
Regimen selection with label checks
Trial eligibility overlay
Guideline citations (NCCN, ASCO)
Example: Type 2 diabetes with chronic kidney disease
Risk stratification and targets
SGLT2/GLP-1 selection by eGFR
Drug-drug interactions from labels
Comorbidity-aware branches
Trial candidates and exclusions